Trial intelligence / Profile preview

DDAVP in Percutaneous Ultrasound-guided Renal Biopsy

NCT00748072Phase 4Completed

Sponsor
University of Bari Aldo Moro
Start
Aug 2008
Primary completion
Aug 2009
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of desmopressin (2 arms), sponsored by University of Bari Aldo Moro. Primary endpoint: Incidence of Post-biopsy Bleeding Complications. Started Aug 2008; status: completed.

02

Drugs

desmopressin

Beyond the preview

Go deeper on NCT00748072.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00748072.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call